A61K 2121/00
Preparations for use in therapy
A61K2121/00 (Preparations for use in therapy) appears on 872 US grants and 891 published applications in this corpus.
Search patents in A61K- Granted patents
- 872
- Published applications
- 891
- Assignees
- 590
- Inventors
- 2,468
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 0 | 0 |
| 1978 | 4 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 5 | 0 |
| 1983 | 1 | 0 |
| 1984 | 8 | 0 |
| 1985 | 3 | 0 |
| 1986 | 5 | 0 |
| 1987 | 7 | 0 |
| 1988 | 11 | 0 |
| 1989 | 23 | 0 |
| 1990 | 19 | 0 |
| 1991 | 27 | 0 |
| 1992 | 36 | 0 |
| 1993 | 22 | 0 |
| 1994 | 35 | 0 |
| 1995 | 28 | 0 |
| 1996 | 24 | 0 |
| 1997 | 54 | 0 |
| 1998 | 56 | 0 |
| 1999 | 44 | 0 |
| 2000 | 34 | 0 |
| 2001 | 24 | 5 |
| 2002 | 16 | 17 |
| 2003 | 9 | 31 |
| 2004 | 8 | 16 |
| 2005 | 6 | 12 |
| 2006 | 10 | 24 |
| 2007 | 10 | 8 |
| 2008 | 8 | 12 |
| 2009 | 5 | 6 |
| 2010 | 5 | 7 |
| 2011 | 3 | 12 |
| 2012 | 10 | 10 |
| 2013 | 2 | 17 |
| 2014 | 11 | 12 |
| 2015 | 12 | 17 |
| 2016 | 12 | 23 |
| 2017 | 22 | 89 |
| 2018 | 33 | 51 |
| 2019 | 36 | 46 |
| 2020 | 37 | 43 |
| 2021 | 25 | 24 |
| 2022 | 22 | 35 |
| 2023 | 12 | 35 |
| 2024 | 26 | 101 |
| 2025 | 29 | 148 |
| 2026 | 29 | 90 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Near-infrared dyes and conjugates for targeting tumors6 Oct 2026US 12,752,023 B2Lahjavida, LLC
- Urokinase plasminogen activator receptor-targeted radiopharmaceutical22 Sep 2026US 12,741,039 B2Monopar Therapeutics Inc.
- Gastrin-releasing peptide receptor (GRPR)-targeted compounds and uses thereof8 Sep 2026US 12,728,175 B2Alpha-9 Oncology, Inc.
- Methods for treating spinocerebellar ataxia type 31 Sep 2026US 12,723,049 B2PTC Therapeutics, Inc.
- Methods and agents for treating acute neuroinflammatory injury25 Aug 2026US 12,714,738 B2Implicit Bioscience Limited
- 18f-fluorinated fatty acids and uses thereof8 Oct 2026US 2026/0308102 A1Ratio Therapeutics, Inc.
- Photoactivatable nanoparticles and uses thereof as agents for immunotherapy combinations1 Oct 2026US 2026/0295050 A1Board of Regents, The University of Texas System
- Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns1 Oct 2026US 2026/0297191 A1ImmunoBrain Checkpoint, Inc.
- Imaging methods and agents for grading and staging and subsequent treatment of prostate cancer in a patient24 Sep 2026US 2026/0284233 A1
- Dosage regimen for short-lived radioisotope24 Sep 2026US 2026/0284241 A1AdvanCell Pty Limited
Most cited
By later US patents
- Medical scanning and treatment system and method1,502US 5,464,013 A1995
- Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers510US 4,331,647 A1982
- Radioactive embolizing compositions503US 6,015,541 AMicro Therapeutics, Inc. · 2000
- Antibody-metal ion complexes348US 4,741,900 ACytogen Corporation · 1988
- Method of targeting tumors in humans336US 5,019,369 AVestar, Inc. · 1991